Literature DB >> 15164879

Runx protein signaling in human cancers.

Ian Anglin1, Antonio Passaniti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15164879     DOI： 10.1007/1-4020-7847-1_10

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  12 in total

1.  RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma.

Authors:  Kant Sangpairoj; Pornpun Vivithanaporn; Somjai Apisawetakan; Sukumal Chongthammakun; Prasert Sobhon; Kulathida Chaithirayanon
Journal:  Cell Mol Neurobiol       Date:  2016-12-24       Impact factor: 5.046

2.  Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.

Authors:  Martha L Slattery; Abbie Lundgreen; Jennifer S Herrick; Bette J Caan; John D Potter; Roger K Wolff
Journal:  Carcinogenesis       Date:  2010-11-18       Impact factor: 4.944

3.  Runx2 protein stabilizes hypoxia-inducible factor-1α through competition with von Hippel-Lindau protein (pVHL) and stimulates angiogenesis in growth plate hypertrophic chondrocytes.

Authors:  Sun-Hee Lee; Xiangguo Che; Jae-Hwan Jeong; Je-Yong Choi; Young-Joo Lee; Yong-Hee Lee; Suk-Chul Bae; You-Mie Lee
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

4.  The GATA factor Serpent cross-regulates lozenge and u-shaped expression during Drosophila blood cell development.

Authors:  Selen Muratoglu; Barry Hough; Soe T Mon; Nancy Fossett
Journal:  Dev Biol       Date:  2007-08-16       Impact factor: 3.582

5.  Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity.

Authors:  Toshinori Ozaki; Hirokazu Sugimoto; Mizuyo Nakamura; Kiriko Hiraoka; Hiroyuki Yoda; Meixiang Sang; Kyoko Fujiwara; Hiroki Nagase
Journal:  FEBS J       Date:  2014-11-10       Impact factor: 5.542

6.  Genetic variants in the TGFβ-signaling pathway influence expression of miRNAs in colon and rectal normal mucosa and tumor tissue.

Authors:  Martha L Slattery; Andromahi Trivellas; Andrew J Pellatt; Lila E Mullany; John R Stevens; Roger K Wolff; Jennifer S Herrick
Journal:  Oncotarget       Date:  2017-03-07

7.  LRG1 promotes proliferation and inhibits apoptosis in colorectal cancer cells via RUNX1 activation.

Authors:  Ying Zhou; Xintian Zhang; Jingjing Zhang; Jingyuan Fang; Zhizheng Ge; Xiaobo Li
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

Review 8.  Therapeutic Approaches Targeting Nucleolus in Cancer.

Authors:  Pietro Carotenuto; Annalisa Pecoraro; Gaetano Palma; Giulia Russo; Annapina Russo
Journal:  Cells       Date:  2019-09-16       Impact factor: 7.666

9.  Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.

Authors:  T Ozaki; D Wu; H Sugimoto; H Nagase; A Nakagawara
Journal:  Cell Death Dis       Date:  2013-04-25       Impact factor: 8.469

10.  Loss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancer.

Authors:  Xiaohui Chen; Yujie Deng; Yi Shi; Weifeng Zhu; Yibin Cai; Chunwei Xu; Kunshou Zhu; Xiongwei Zheng; Gang Chen; Qi Xie; Guoxing Weng
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.